Medicare Part D drug Data year 2024 Brand name Source: CMS Part D Prescribers

Humira(Cf) Pen

Adalimumab

Open in the dashboard

Part D claims

437,072

Prescriptions dispensed, refills included

Drug cost

$3,795,159,532

Paid at the pharmacy, in all

Prescribers

11,704

With 11 or more claims of it

In 2024, Medicare Part D recorded 437,072 claims for Humira(Cf) Pen (adalimumab) from 11,704 prescribers, at a total drug cost of $3.8 billion paid at the pharmacy by Medicare, patients and others.

Where it is prescribed

By the prescriber's state · 52 states and territories
Part D claims for Humira(Cf) Pen by the state of the prescriber, 2024
State Relative to the most Prescribers Claims Drug cost
NY 791 30,722 $274,275,813
TX 760 30,671 $265,822,670
CA 795 28,547 $239,150,041
FL 711 25,633 $219,063,436
NC 479 19,079 $171,682,186
MI 437 18,644 $158,986,263
PA 554 18,561 $164,368,106
OH 482 16,902 $148,175,129
IL 454 16,842 $145,677,761
MA 407 15,954 $139,122,426
GA 374 13,654 $121,699,435
PR 158 12,298 $89,155,313
TN 294 11,859 $102,250,604
WI 292 11,680 $100,723,551
IN 258 10,437 $90,057,642
The other 37 states and territories
State Prescribers Claims Drug cost
SC 242 10,422 $99,357,791
MO 258 9,244 $84,730,466
LA 183 8,980 $75,817,947
VA 274 8,703 $78,982,556
NJ 267 8,640 $73,412,622
AL 187 8,320 $72,750,311
WA 268 8,284 $72,719,249
KY 220 8,205 $67,506,209
AZ 210 7,190 $63,644,418
OK 156 6,328 $54,138,616
MN 203 5,791 $48,504,095
CT 162 5,483 $51,800,926
MD 185 5,368 $48,979,797
CO 164 5,333 $46,415,982
MS 116 4,903 $40,903,236
OR 141 4,539 $37,752,800
WV 98 3,931 $34,171,044
AR 113 3,638 $31,320,352
KS 90 3,291 $28,441,805
IA 103 2,992 $26,246,811
ME 72 2,959 $27,440,928
NV 79 2,506 $20,953,191
ID 80 2,486 $21,040,758
NM 58 2,349 $19,836,986
NH 72 2,101 $17,724,549
VT 31 1,812 $16,625,403
UT 74 1,662 $14,465,001
RI 46 1,512 $13,155,610
NE 63 1,504 $13,191,427
MT 41 1,351 $11,549,199
DE 37 1,187 $11,661,394
SD 32 1,027 $7,392,328
AK 26 886 $9,688,235
HI 29 821 $6,059,899
DC 32 750 $7,641,611
ND 29 718 $5,877,565
WY 17 373 $3,048,041

The state is where the prescriber practices, not where the patient lives. Totals are Medicare Part D claims only.

Which specialties prescribe it

Top 15 of 44
Part D claims for Humira(Cf) Pen by prescriber specialty, 2024
Specialty Relative to the most Prescribers Claims Drug cost
Rheumatology 3,848 228,449 $1,887,061,041
Nurse Practitioner 1,432 46,132 $406,225,947
Gastroenterology 2,112 44,086 $410,996,170
Physician Assistant 1,432 41,815 $388,457,735
Dermatology 1,597 35,326 $354,449,715
Internal Medicine 741 27,978 $232,100,133
Family Practice 211 3,482 $30,218,194
Ophthalmology 87 3,283 $26,640,976
Student in an Organized Health Care Education/Training Program 63 1,130 $11,080,647
Pharmacist 28 1,012 $8,850,480
Allergy/ Immunology 16 913 $7,352,165
Hospitalist 15 580 $4,612,061
Pulmonary Disease 16 448 $4,624,210
General Practice 25 384 $3,200,891
Specialist 5 249 $1,957,818

Specialty is the one printed on each prescriber's Medicare claims.

Largest prescribers

First 5 of 100 by claims · 2024

Two separate records. Claims come from Medicare and related payments from Open Payments. They are shown in one row because they name the same product; they do not show that a payment affected a prescription.

The prescribers with the most Part D claims of this drug in 2024
Prescriber Specialty State Claims Drug cost Related payments
Anne Holly Physician Assistant NY 902 $8,430,593 None on record
Michael Babilonia Roman Internal Medicine PR 734 $5,086,155 None on record
Amanda Matthews Physician Assistant TX 688 $5,337,137 None on record
Wilfredo Villarrubia Physician Assistant SC 640 $5,683,211 None on record
Rajiv Shah Ophthalmology NC 595 $4,268,450 None on record

"No profile" means the prescriber has no Open Payments record here; "None on record" means no payment naming this product in the payment year. Related payments are general payments, and one that names several products is split evenly, so an amount is payments related to the product, not money paid for it. The list is the prescribers with the most claims, up to 100 per drug.

See more in the dashboard: 25 with a free account, all 100 with Patron

Industry payments naming this drug

From CMS Open Payments

Open Payments names products as manufacturers reported them, and CMS does not link them to Part D drugs, so this match is by name and ours. The two records are separate: they do not show that a payment affected a prescription.

Other names for adalimumab

What this means

Medicare Part D is the part of Medicare that covers prescription drugs dispensed at a pharmacy. Each year CMS publishes, for every prescriber and drug, how many claims were dispensed and what they cost. This page adds those up for one drug.

A claim is one prescription filled, refills included. Drug cost is the total paid at the pharmacy by Medicare, the patient and anyone else; it is not money to the prescriber. CMS leaves out any prescriber with fewer than 11 claims of a drug, so the prescriber count is a floor and a missing prescriber does not mean none.

Part D covers drugs dispensed to Medicare beneficiaries at a pharmacy. It does not include drugs given in a clinic or hospital, patients with other insurance, or the most recent year, which Medicare publishes about two years behind.

Provenance

Source: CMS Medicare Part D Prescribers by Provider and Drug · data year 2024

We reproduce what CMS published. We do not verify, edit or correct the underlying records.

A prescription record is not evidence of wrongdoing, and nothing here is medical advice. Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency.

How to dispute or correct a record